Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis
Mice lacking monoacylglycerol acyltransferase 2 (mMGAT21) are resistant to diet-induced fatty liver, suggesting hMOGAT2 inhibition is a viable option for treating metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH). We generated hu...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2024-12-01
|
| Seri Bilgileri: | Journal of Lipid Research |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S0022227524002001 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
